FDA Approves StrataGraft for Deep Skin Burns
Medscape,
The US Food and Drug Administration (FDA) has approved a novel regenerative therapy that could be an alternative to…
The US Food and Drug Administration (FDA) has approved a novel regenerative therapy that could be an alternative to…
STAINES-UPON-THAMES - Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced that the U.S.
- StrataGraft® Skin Tissue, If Approved, Could Reduce or Eliminate the Need for Autografting of Healthy Skin to Treat Burn…
- StrataGraft® Skin Tissue, If Approved, Could Reduce or Eliminate the Need for Autografting of Healthy Skin to Treat Burn…